Tdoc Marketbeat

Dari Bertanya Jadi Mengerti

Tdoc Marketbeat. Compare key medical stocks including teladoc health, vertex pharmaceuticals, and abbott laboratories at marketbeat. Most likely, a revisit of $300 isn’t in the cards this year.

kaiser permanente stock ticker Entrenched Online Journal Picture Gallery
kaiser permanente stock ticker Entrenched Online Journal Picture Gallery

The proof is in the company’s profit. Nyse tdoc traded up $2.90 during trading hours on friday, reaching $33.59. The future growth projections help to explain why the median price target analysts currently have on tdoc stock is $161, which is 81% higher than where the share price currently sits.

kaiser permanente stock ticker Entrenched Online Journal Picture Gallery

The proof is in the company’s profit. According to marketbeat.com, teladoc health presently has a consensus rating of “hold” and a consensus target price of $96.79. Tdoc stock has solid fundamental footing fundamentally, the business is healthy and that’s not just an opinion. The consensus recommendation for teladoc stock (as of 1 march 2022) was bullish, with 13 out of 25 analysts currently rating the stock as a ‘buy’ according to data compiled by marketbeat.

← shireen lankaranishireen lankarani →